Gilead, LEO Pharma partner to develop programs for inflammatory diseases
Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs to treat ...
Gilead in pact for anti-inflammatory drugs in a deal worth up to $1.7B
Gilead Sciences (GILD) partners with LEO Pharma in a $1.7B agreement to develop anti-inflammatory drugs. Read more here.
Bernstein Sticks to Its Buy Rating for Gilead Sciences (GILD)
In a report released yesterday, Courtney Breen from Bernstein maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...
Nature21h
Aims and scope
Humanities & Social Sciences Communications is a fully open-access, online journal publishing peer-reviewed research from across—and between—all areas of the humanities, behavioral and social ...
pharmaphorum19h
The B2C prescription: Marketing lessons for B2B pharma companies
Some pharmaceutical brands are even experimenting with influencers, including a recent campaign from Gilead Science. Meanwhile, Kantar recorded a 208% jump in spending on podcast pharma ads in ...